financial results

Boston Scientific faces securities fraud investigation after 17.6% stock drop triggered by weaker-than-expected electrophysiology division sales in Q4 2025 results.

$OSS to report Q4 2025 earnings March 18, offering insight into edge AI computing demand across autonomous vehicles, defense, and robotics markets.

$AFCG reported Q4 2025 profit but full-year loss of $20.7M. Company declared Q1 2026 dividend while executing BDC conversion strategy.

HERE Group Limited will report Q2 fiscal 2026 earnings on March 12, 2026, with management discussing results via conference call at 7:00 A.M. ET.

Comscore will discuss fourth quarter and full year 2025 results on March 17, 2026 via webcast and phone conference.

Immunocore Holdings announced presentations at five major investor conferences in March 2026, showcasing its commercial-stage biotech platform and pipeline to institutional investors.

GDS Holdings will report 2025 earnings March 17, 2026 before market open, with conference call at 8:00 AM ET. The China data center operator faces investor scrutiny on capacity utilization, customer concentration, and AI infrastructure demand.

Finnish packaging company Huhtamäki reports €4.0 billion in 2025 net sales with ESRS-compliant sustainability reporting and independent KPMG verification.

Huhtamaki reported €4.0 billion revenue for 2025 despite currency headwinds, with audited ESEF and ESRS-compliant reporting.

Bragar Eagel & Squire investigates $ODDITY for potential securities violations after algorithm changes caused advertising partner disruption and significant stock decline.

$QUBT reports Q4 2025 revenues of $198K, up 219% YoY. Company raised $750M, acquired Luminar Semiconductor for $110M, narrowing net loss significantly.

Danish biotech $EVAX will announce full-year 2025 financial results and business update March 5, detailing AI-Immunology platform development across oncology, infectious disease, and autoimmune applications.

Eltek Ltd. ($ELTK) will release Q4 2025 and full-year results March 9, 2026, with a management conference call at 9:30 a.m. ET featuring CEO Eli Yaffe and CFO Ron Freund.

HighPeak Energy will release 2025 full-year results March 11, 2026, with investor conference call March 12 at 10 a.m. Central Time.

Viomi Technology will report 2025 full-year financial results on March 25, 2026, with management conference call at 8:00 A.M. ET.

Chinese content community Zhihu will release Q4 and full-year 2025 financial results on March 25, 2026, followed by management discussion call.

Arcutis will present pipeline progress and 2025 financial results at TD Cowen Healthcare Summit in March 2026, advancing its dermatology portfolio and patient awareness initiatives.

Minerals Technologies to present at four major investor conferences in March 2026, with CEO and CFO discussing strategic direction and financial performance.

Mesoblast reports strong H1 results with Ryoncil® revenue of $51.3M and narrowed net losses. Commercial expansion underway with 49 transplant centers operational and FY2026 guidance of $110-120M revenue.

Algoma Steel will release 2025 full-year results on March 11, 2026, followed by an investor call. The company continues transitioning to electric arc furnace technology to reduce emissions.